Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03797859 Enrolling by invitation - Apnea Clinical Trials

THRIVE Apneic Ventilation With Standardized Airway Management During General Anesthesia.

Start date: January 8, 2019
Phase:
Study type: Observational

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) denotes the use of high-flow humidified nasal oxygen system (for example Optiflow®) as an alternative ventilation modality for an anesthetized patient without spontaneous respiration. This method requires only basic airway management manoeuvres to keep the airway open and provides both stable longterm oxygenation as well as apneic ventialtion. We plan to evaluate this methods physiological performance under standardized conditions of airway management by frequent, repeated arterial blood gas analyses.

NCT ID: NCT03781752 Enrolling by invitation - Clinical trials for Attention Deficit Hyperactivity Disorder

Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

Start date: March 4, 2018
Phase: Phase 4
Study type: Interventional

The study team will determine the association between d,l-methylphenidate (MPH) therapeutic outcomes in ADHD patients and genetic variants of CES1 and reveal key associations between CES1 genotypes and the PK and PD of MPH.

NCT ID: NCT03724136 Enrolling by invitation - Alzheimer Disease Clinical Trials

Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study

ACIST
Start date: October 24, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the use of autologous Bone Marrow Derived Stem Cells (BMSC) as a means to improve cognitive impairment as occurs in Alzheimer's Disease and other dementias and to improve behavior and socialization issues which occur in adult Autism Spectrum Disorder. The use of Near Infrared Light, in conjunction with the use of BMSC, will also be assessed.

NCT ID: NCT03721692 Enrolling by invitation - Clinical trials for Acute Ischemic Cerebral Vascular Disease

Remote Ischemic Conditioning in Acute Ischemic Cerebral Vascular Disease Patients With Coexistence of Cerebral and Coronary Atherosclerosis(RIC-CCCA)

Start date: January 17, 2018
Phase: N/A
Study type: Interventional

Remote ischemic conditioning(RIC) is a protective systemic strategy by organs brief and sublethal ischemia to confer protection from subsequent severe ischemia in distant organs, especially for heart and brain. This study will discuss whether RIC can play a part in preventing the patients with coexistence of cerebral and coronary atherosclerosis from the recurrence of cerebral vascular disease(CVD) or coronary artery disease(CAD). This study selects patients who suffered an ischemic stroke within 14 days prior to enrollment. All patients complete cerebral and coronary artery assessment. And then the the investigators select the patients who both have at least one cerebral vascular and at least one coronary artery stenosis over 50%, or the patients who both have at least one cerebral vascular stenosis over 50% and myocardial ischemic events history. These patients will randomly divide into two groups, RIC group and non-RIC group. Non-RIC group will only accept cardio-cerebrovascular disease secondary prevention treatment. RIC group will use not only cardio-cerebrovascular disease secondary prevention treatment, but also RIC everyday for three months, 5 cycles 5min ischemic-5min reperfusion each day. For the first month, the the investigators will call RIC group patients every week for insuring compliance and adverse effect. All patients will follow up endpoint events, cardio-cerebrovascular disease secondary prevention treatment, and the adverse effect every three months, up to one year.

NCT ID: NCT03713229 Enrolling by invitation - Clinical trials for Anal Squamous Intraepithelial Neoplasia

Seville Cohort of People Living With HIV at Risk for Anal Cancer

SeVIHanal
Start date: September 1, 2010
Phase:
Study type: Observational

There is increasing awareness of augmenting risk of anal cancer in people living with HIV, especially among men who have sex with men (MSM). High resolution anoscopy (HRA) represents the gold standard to detect pre-cancerous anal high-grade squamous intraepithelial lesions (HSIL), however, the procedure is time-consuming, costly and, most importantly, the learning curve is very flat. This yields a poor implementation of anal screening and, likely, to an excess of otherwise preventable anal cancer. Other screening methods include digital ano-rectal examination, anal-rectal cytology and human papillomavirus (HPV) genotyping, since infection with high-risk HPV genotypes has been identified as the main reason for the development of HSIL. To date, there is no consensus in screening strategies. Furthermore, it remains unclear whether, in whom and to which extend the currently available topic and invasive treatment options for HSIL should be applied, given that the natural history of the development of anal cancer remains poorly understood. The present cohort study aims to provide real-life data on the screening, management and follow-up of HIV-infected MSM is warranted for a better understanding of anal cancer in this setting.

NCT ID: NCT03711175 Enrolling by invitation - Clinical trials for Severe Arthropathy With a Grossly Deficient Rotator Cuff

The Influence of Repairing the Sub-scapularis on Outcomes After Reverse Arthroplasty

Start date: September 28, 2018
Phase: N/A
Study type: Interventional

The study is a prospective, multi-center, randomized blinded study to determine how repairing the subscapularis vs. not repairing the subscapularis when subjects are implanted with the AltiVate Reverse® Shoulder System for reverse total shoulder arthroplasty affects isometric and isokinetic internal rotational strength. It is hypothesized that patients in which the subscapularis is repaired will have improved postoperative isometric and isokinetic internal rotational strength.

NCT ID: NCT03702023 Enrolling by invitation - Clinical trials for Post Electrophysiology Procedure Pain

Oral Acetaminophen Use for Pain Reduction in Electrophysiology Procedures

Start date: February 8, 2019
Phase: Phase 4
Study type: Interventional

The investigators are purposing a study to evaluate the use of acetaminophen given prior to an electrophysiology procedure and post procedural pain control.

NCT ID: NCT03701828 Enrolling by invitation - Clinical trials for Non-Alcoholic Fatty Liver Disease

Liver Health and Metabolic Function in People With Obesity

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This project aims to determine the effect of significant weight loss on rates on hepatic fibrogenesis in people with obesity.

NCT ID: NCT03687853 Enrolling by invitation - Liver Metastases Clinical Trials

Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer

NCT ID: NCT03685903 Enrolling by invitation - Clinical trials for Patients Indicated for Periampullary or Pancreaticobiliary Examination

Study for the Detection of Duodenal Papilla Using Capsule Endoscopy and Comparison of Images With EUS/ERCP Procedure.

Start date: September 26, 2018
Phase: Phase 1
Study type: Interventional

This observational Non-Significant Risk (NSR) Study will be used to assess the ability of CapsoCam® Plus (SV-3) capsule endoscope to detect the duodenal papilla and visualize pathology or abnormalities in the periampullary area and will prospectively compare the capsule endoscopy and EUS/ERCP pictorial images acquired in procedures conducted in a minimum of 20 and a maximum of 200 research patients.